| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 10/12/2011 | CN101569608B Oral solid lipid nano-particle preparation of calcitonin and preparation method thereof |
| 10/12/2011 | CN101264158B Application of Chinese medicine composing prescription in preparing medicaments for treating metabolic syndrome |
| 10/11/2011 | US8034807 Salts of bazedoxifene |
| 10/11/2011 | US8034379 Hydrophilic gel foaming matrix; cellulose ethers |
| 10/11/2011 | CA2504907C Indoles useful in the treatment of androgen-receptor related diseases |
| 10/11/2011 | CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases |
| 10/11/2011 | CA2457054C Activator of peroxisome proliferator-activated receptor .delta. |
| 10/11/2011 | CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 10/06/2011 | WO2011098262A3 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth |
| 10/06/2011 | US20110245342 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof |
| 10/06/2011 | US20110245314 Extended Release Formulation and Methods of Treating Adrenergic Dysregulation |
| 10/06/2011 | US20110245261 Antiprolactinic veterinary composition for ruminants |
| 10/06/2011 | US20110245216 Use of dhea derivatives for enhancing physical performance |
| 10/06/2011 | US20110245215 Transdermal delivery systems for active agents |
| 10/06/2011 | US20110245212 Methods of alleviating the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
| 10/06/2011 | US20110245172 Biocompatible oligomer-polymer compositions |
| 10/06/2011 | US20110245159 Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same |
| 10/06/2011 | US20110243902 Method for treating or preventing a pancreatic dysfunction |
| 10/06/2011 | US20110243890 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus |
| 10/05/2011 | EP2371367A1 Method of treating men with testosterone supplement and 5alpha reductase inhibitor |
| 10/05/2011 | EP2370441A1 Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists |
| 10/05/2011 | EP2370086A2 Methods and compositions for altering health, wellbeing, and lifespan |
| 10/05/2011 | EP2370072A1 Phytoestrogenic compositions for preventing or treating symptoms associated with menopause |
| 10/05/2011 | EP1463497B1 Treating muscle wasting with selective androgen receptor modulators |
| 10/05/2011 | EP1406633B1 Enhanced drug delivery in transdermal systems |
| 10/05/2011 | EP1377276B1 Timed pulse release composition |
| 10/05/2011 | CN1845933B Specific glucocorticosteriod compound having anti-inflamatory activity |
| 10/05/2011 | CN102206277A Antibodies that bind human interleukin-18 and methods of making and using |
| 10/05/2011 | CN102206217A Heterocyclic compounds for treating or preventing diabetes mellitus as dipeptidyl peptidase inhibitor |
| 10/05/2011 | CN102205074A Chinese medicinal composition and application thereof |
| 10/05/2011 | CN102204918A Steroid compound agonist for PPARgamma and its purpose |
| 10/05/2011 | CN102204894A Iodized lecithin enteric capsule preparation and preparation method thereof |
| 10/05/2011 | CN101415720B 11-phosphorous steroid derivatives useful as progesterone receptor modulators |
| 10/05/2011 | CN101323604B Novel PPAR alpha/beta dual agonist, preparation and use thereof |
| 10/04/2011 | US8030517 CCR9 inhibitors and methods of use thereof |
| 10/04/2011 | US8030336 Nicotinamide-based kinase inhibitors |
| 10/04/2011 | US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 10/04/2011 | US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides |
| 10/04/2011 | CA2371839C Hydroxymatairesinol in cancer prevention |
| 09/29/2011 | WO2011119194A1 Compositions and methods for non-toxic delivery of antiprogestins |
| 09/29/2011 | WO2011118843A1 Glutamate derivatives or salts thereof |
| 09/29/2011 | US20110238003 Method for systemic drug delivery through the nail |
| 09/29/2011 | US20110237562 Use of a container of an inorganic additive containing plastic material |
| 09/29/2011 | US20110237532 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal |
| 09/29/2011 | US20110237509 hGH AND METHODS FOR PREPARING hGH |
| 09/29/2011 | US20110237504 Delivery agents for enhancing mucosal absorption of therapeutic agents |
| 09/29/2011 | US20110237493 Dipeptide linked medicinal agents |
| 09/29/2011 | US20110236994 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/29/2011 | US20110236358 Composition comprising isoflavones |
| 09/29/2011 | CA2793712A1 Compositions and methods for non-toxic delivery of antiprogestins |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2367808A2 PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a-YL) PROPIONIC ACID g-LACTONES |
| 09/28/2011 | EP2367793A1 Gpr120 receptor agonists and uses thereof |
| 09/28/2011 | EP2367449A1 Composition comprising isoflavones |
| 09/28/2011 | EP1536826B1 Igf-2 peptide for use in tolerogenic approaches for type i diabetes. |
| 09/28/2011 | EP1424330B1 Activator for peroxisome proliferator-responsive receptor delta |
| 09/28/2011 | EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO |
| 09/28/2011 | EP1420800B1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 09/28/2011 | EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/28/2011 | EP1144613B1 Methods for making proteins containing free cysteine residues |
| 09/28/2011 | CN102203093A Aminotriazolopyridines and their use as kinase inhibitors |
| 09/28/2011 | CN102198108A Process for preparing Cinacalcet hydrochloride tablets or capsules |
| 09/28/2011 | CN101891738B Dasatinib polymorph and preparation method and medical composition thereof |
| 09/27/2011 | US8026228 Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
| 09/27/2011 | US8026212 Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues |
| 09/27/2011 | US8025898 Enhanced drug delivery in transdermal systems |
| 09/27/2011 | CA2495280C Topical pharmaceutical carrier |
| 09/27/2011 | CA2405811C Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases |
| 09/22/2011 | WO2011115183A1 Novel monocyclic pyrimidine derivative |
| 09/22/2011 | WO2011113363A1 Agomelatine hydrobromide hydrate and preparation thereof |
| 09/22/2011 | WO2011074931A3 Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome |
| 09/22/2011 | US20110230555 Enzyme Inhibitors and the Use Thereof |
| 09/22/2011 | US20110230539 Small Molecule Inhibitors of N-Terminus Activation of the Androgen Receptor |
| 09/22/2011 | US20110230517 Calcium receptor modulating agents |
| 09/22/2011 | US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/22/2011 | US20110230464 Purine derivatives useful as p13 kinase inhibitors |
| 09/22/2011 | US20110230414 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230404 Glycoproteins Produced in Plants and Methods of Their Use |
| 09/22/2011 | US20110229574 Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
| 09/22/2011 | CA2792430A1 Agomelatine hydrobromide hydrate and preparation thereof |
| 09/21/2011 | EP2366395A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
| 09/21/2011 | EP2365955A1 Aryl di-substituted propenone compounds |
| 09/21/2011 | EP1274464B1 Compositions and methods for regulated protein expression in gut |
| 09/21/2011 | CN102197044A Peptide having anti-diabetic activity and use thereof |
| 09/21/2011 | CN102191305A Preparation method of hoof nail polypeptide through composite hydrolysis |
| 09/21/2011 | CN102191160A Method for brewing estrogen health wine by using natural plant |
| 09/21/2011 | CN102188705A Medicament composition containing bis cyclooctane derivatives |
| 09/21/2011 | CN102188514A Application of medicinal composition in process of preparing medicine for preventing and treating hyperprolactinemia |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2525470C External patch containing estrogen and/or progestogen |
| 09/20/2011 | CA2508923C Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 09/20/2011 | CA2467237C Method of preventing or treating benign gynaecological disorders |
| 09/20/2011 | CA2455328C New use of cyclolignans and new cyclolignans |
| 09/20/2011 | CA2417904C Compounds acting as melanocortin receptor ligands |
| 09/20/2011 | CA2225796C Novel formulation for peptide release |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | US20110224254 Novel inhibitors |
| 09/15/2011 | US20110224253 Small-molecule inhibitors of the androgen receptor |